These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 9201678)
41. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease. Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483 [TBL] [Abstract][Full Text] [Related]
42. Age dependency of the regional cerebral blood volume (rCBV) measured with dynamic susceptibility contrast MR imaging (DSC). Wenz F; Rempp K; Brix G; Knopp MV; Gückel F; Hess T; van Kaick G Magn Reson Imaging; 1996; 14(2):157-62. PubMed ID: 8847971 [TBL] [Abstract][Full Text] [Related]
43. Correcting saturation effects of the arterial input function in dynamic susceptibility contrast-enhanced MRI: a Monte Carlo simulation. Brunecker P; Villringer A; Schultze J; Nolte CH; Jungehülsing GJ; Endres M; Steinbrink J Magn Reson Imaging; 2007 Nov; 25(9):1300-11. PubMed ID: 17462846 [TBL] [Abstract][Full Text] [Related]
44. Comparison of contrast agents with high molarity and with weak protein binding in cerebral perfusion imaging at 3 T. Thilmann O; Larsson EM; Björkman-Burtscher IM; Ståhlberg F; Wirestam R J Magn Reson Imaging; 2005 Nov; 22(5):597-604. PubMed ID: 16200539 [TBL] [Abstract][Full Text] [Related]
45. Time-dependency in brain lesion enhancement with gadodiamide injection. Akeson P; Nordström CH; Holtås S Acta Radiol; 1997 Jan; 38(1):19-24. PubMed ID: 9059396 [TBL] [Abstract][Full Text] [Related]
46. An independent component analysis approach for minimizing effects of recirculation in dynamic susceptibility contrast magnetic resonance imaging. Wu Y; An H; Krim H; Lin W J Cereb Blood Flow Metab; 2007 Mar; 27(3):632-45. PubMed ID: 16850030 [TBL] [Abstract][Full Text] [Related]
47. [Systematic analysis of the geometry of a defined contrast medium bolus--implications for contrast enhanced 3D MR-angiography of thoracic vessels]. Kreitner KF; Kunz RP; Weschler C; Ley S; Krummenauer F; Schreiber WG; Thelen M Rofo; 2005 May; 177(5):646-54. PubMed ID: 15871079 [TBL] [Abstract][Full Text] [Related]
48. Contrast-enhanced three-dimensional pulmonary perfusion magnetic resonance imaging: intraindividual comparison of 1.0 M gadobutrol and 0.5 M Gd-DTPA at three dose levels. Fink C; Puderbach M; Ley S; Plathow C; Bock M; Zuna I; Kauczor HU Invest Radiol; 2004 Mar; 39(3):143-8. PubMed ID: 15076006 [TBL] [Abstract][Full Text] [Related]
49. Dynamic susceptibility contrast MR imaging: correlation of signal intensity changes with cerebral blood volume measurements. Cha S; Lu S; Johnson G; Knopp EA J Magn Reson Imaging; 2000 Feb; 11(2):114-9. PubMed ID: 10713942 [TBL] [Abstract][Full Text] [Related]
51. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla. Giesel FL; Mehndiratta A; Risse F; Rius M; Zechmann CM; von Tengg-Kobligk H; Gerigk L; Kauczor HU; Politi M; Essig M; Griffiths PD; Wilkinson ID Acta Radiol; 2009 Jun; 50(5):521-30. PubMed ID: 19337867 [TBL] [Abstract][Full Text] [Related]
52. High spatial resolution and high contrast visualization of brain arteries and veins: impact of blood pool contrast agent and water-selective excitation imaging at 3T. Spuentrup E; Jacobs JE; Kleimann JF; Wiethoff AJ; Poggenborg J; Brinker G; Loehr M; Möller-Hartmann W; Botnar RM; Ernestus RI; Lackner KJ Rofo; 2010 Dec; 182(12):1097-104. PubMed ID: 20803412 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of gadodiamide versus gadobutrol for contrast-enhanced MR imaging in a rat brain glioma model at 1.5 and 3 T. Morelli JN; Runge VM; Vu L; Loynachan AT; Attenberger UI Invest Radiol; 2010 Dec; 45(12):810-8. PubMed ID: 20856127 [TBL] [Abstract][Full Text] [Related]
55. Minimizing macrovessel signal in cerebral perfusion imaging using independent component analysis. Reishofer G; Fazekas F; Keeling S; Enzinger C; Payer F; Simbrunner J; Stollberger R Magn Reson Med; 2007 Feb; 57(2):278-88. PubMed ID: 17260383 [TBL] [Abstract][Full Text] [Related]
56. Adaptive total linear least square method for quantification of mean transit time in brain perfusion MRI. Li X; Tian J; Li E; Wang X; Dai J; Ai L Magn Reson Imaging; 2003 Jun; 21(5):503-10. PubMed ID: 12878260 [TBL] [Abstract][Full Text] [Related]
57. Autoregressive moving average (ARMA) model applied to quantification of cerebral blood flow using dynamic susceptibility contrast-enhanced magnetic resonance imaging. Murase K; Yamazaki Y; Shinohara M Magn Reson Med Sci; 2003 Jul; 2(2):85-95. PubMed ID: 16210825 [TBL] [Abstract][Full Text] [Related]
58. Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model. Merkle EM; Dale BM; Barboriak DP Acad Radiol; 2007 Jul; 14(7):795-803. PubMed ID: 17574130 [TBL] [Abstract][Full Text] [Related]
59. Visualization of subtle contrast-related intensity changes using temporal correlation. Wood GK; Berkowitz BA; Wilson CA Magn Reson Imaging; 1994; 12(7):1013-20. PubMed ID: 7997088 [TBL] [Abstract][Full Text] [Related]
60. Impact of fitting algorithms on errors of parameter estimates in dynamic contrast-enhanced MRI. Debus C; Floca R; Nörenberg D; Abdollahi A; Ingrisch M Phys Med Biol; 2017 Nov; 62(24):9322-9340. PubMed ID: 28858856 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]